MX2010003719A - Vacuna de mycoplasma bovis y metodos de uso de la misma. - Google Patents

Vacuna de mycoplasma bovis y metodos de uso de la misma.

Info

Publication number
MX2010003719A
MX2010003719A MX2010003719A MX2010003719A MX2010003719A MX 2010003719 A MX2010003719 A MX 2010003719A MX 2010003719 A MX2010003719 A MX 2010003719A MX 2010003719 A MX2010003719 A MX 2010003719A MX 2010003719 A MX2010003719 A MX 2010003719A
Authority
MX
Mexico
Prior art keywords
mycoplasma bovis
bovis
bovis vaccine
present
bacteria
Prior art date
Application number
MX2010003719A
Other languages
English (en)
Inventor
Jeffrey KNITTEL
Michael Beck
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of MX2010003719A publication Critical patent/MX2010003719A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)

Abstract

La presente invenci?n se refiere a nuevas cepas bacterianas de M. bovis atenuadas. Adem?s, la presente invenci?n tambi?n proporciona composiciones inmunog?nicas que comprenden bacterias vivas de esas cepas de bacterias M. bovis atenuadas, su fabricaci?n y su uso para el tratamiento y profilaxis de infecciones por M. bovis.
MX2010003719A 2007-10-29 2008-10-29 Vacuna de mycoplasma bovis y metodos de uso de la misma. MX2010003719A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98348207P 2007-10-29 2007-10-29
US7555208P 2008-06-25 2008-06-25
PCT/US2008/081545 WO2009058833A2 (en) 2007-10-29 2008-10-29 Mycoplasma bovis vaccine

Publications (1)

Publication Number Publication Date
MX2010003719A true MX2010003719A (es) 2010-04-27

Family

ID=40591728

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003719A MX2010003719A (es) 2007-10-29 2008-10-29 Vacuna de mycoplasma bovis y metodos de uso de la misma.

Country Status (14)

Country Link
US (1) US8652481B2 (es)
EP (1) EP2214702B1 (es)
JP (2) JP2011500093A (es)
KR (2) KR101656301B1 (es)
CN (2) CN103667125A (es)
AR (1) AR069087A1 (es)
BR (1) BRPI0819149B1 (es)
CA (1) CA2699218C (es)
CL (1) CL2008003202A1 (es)
MX (1) MX2010003719A (es)
NZ (1) NZ585588A (es)
SG (1) SG185932A1 (es)
UY (1) UY31437A1 (es)
WO (1) WO2009058833A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110059437A1 (en) * 2006-09-07 2011-03-10 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
AR069087A1 (es) 2007-10-29 2009-12-30 Boehringer Ingelheim Vetmed Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
US8503527B2 (en) 2008-10-03 2013-08-06 Qualcomm Incorporated Video coding with large macroblocks
NZ591950A (en) 2008-10-31 2012-12-21 Boehringer Ingelheim Vetmed Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
WO2014105671A1 (en) * 2012-12-28 2014-07-03 Boehringer Ingelheim Vetmedica Gmbh Immunogenic composition comprising mycoplasma antigens
WO2014105672A1 (en) 2012-12-28 2014-07-03 Boehringer Ingelheim Vetmedica Gmbh Method of making a mycoplasma vaccine
CN115141772A (zh) 2015-08-14 2022-10-04 硕腾服务有限责任公司 牛支原体组合物
CN105441368B (zh) * 2016-01-19 2019-01-01 福清市默克兽医院 一株牛支原体及其应用
CN107118262A (zh) * 2016-02-24 2017-09-01 华中农业大学 一种牛支原体MbovP579蛋白及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7007A (en) * 1850-01-08 Improvement in machinery for making cotton cordage
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
EP0994944A1 (en) * 1997-07-10 2000-04-26 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Method of attenuating pathogenic mycobacteria and strains of mycobacteria so attenuated
EP0965639A1 (en) 1998-06-05 1999-12-22 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
CN1191092C (zh) * 1999-03-26 2005-03-02 沃尔特里德军事研究院 多价登革病毒疫苗
BR0015398A (pt) * 1999-11-08 2002-06-25 Biomune Vacinas para mycoplasma bovis e processos de uso
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin
US20030147914A1 (en) 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
EP1521592A2 (en) * 2001-07-02 2005-04-13 Pfizer Products Inc. Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
MXPA04001872A (es) * 2001-08-28 2004-06-15 Pfizer Prod Inc Modelo de exposicion a micoplasma bovis, procedimiento para administrar m. bovis y procedimientos para inducir lesiones pulmonares neumonicas.
DE102004025452A1 (de) 2004-05-19 2006-01-19 Boehringer Ingelheim Vetmedica Gmbh Vakzine enthaltend BVDV
US20070009545A1 (en) * 2005-07-07 2007-01-11 Joachim Frey Mycoplasma subunit vaccine
US20110059437A1 (en) * 2006-09-07 2011-03-10 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
US20090068231A1 (en) * 2007-09-11 2009-03-12 Wyeth Live attenuated mycoplasma strains
AR069087A1 (es) 2007-10-29 2009-12-30 Boehringer Ingelheim Vetmed Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
NZ589981A (en) 2008-07-03 2012-11-30 Univ Iowa State Res Found Inc Cattle vaccines comprising a disrupted M. bovis bacterium
NZ591950A (en) * 2008-10-31 2012-12-21 Boehringer Ingelheim Vetmed Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada

Also Published As

Publication number Publication date
EP2214702A4 (en) 2010-12-22
AU2008318793A1 (en) 2009-05-07
BRPI0819149A2 (pt) 2020-08-25
EP2214702A2 (en) 2010-08-11
UY31437A1 (es) 2009-05-29
JP2013223511A (ja) 2013-10-31
KR101656301B1 (ko) 2016-09-12
NZ585588A (en) 2012-09-28
US20090130148A1 (en) 2009-05-21
CN101827605A (zh) 2010-09-08
JP2011500093A (ja) 2011-01-06
CN101827605B (zh) 2016-05-04
CA2699218C (en) 2019-09-10
WO2009058833A3 (en) 2009-06-18
KR20160095185A (ko) 2016-08-10
CN103667125A (zh) 2014-03-26
JP5789897B2 (ja) 2015-10-07
KR20100084626A (ko) 2010-07-27
EP2214702B1 (en) 2018-07-04
WO2009058833A2 (en) 2009-05-07
SG185932A1 (en) 2012-12-28
US8652481B2 (en) 2014-02-18
CA2699218A1 (en) 2009-05-07
CL2008003202A1 (es) 2009-11-27
AR069087A1 (es) 2009-12-30
BRPI0819149B1 (pt) 2021-11-23

Similar Documents

Publication Publication Date Title
MX2011010976A (es) Vacunas que comprenden cepas de mycoplasma bovis atenuadas y metodo para la atenuacion.
MX2010003719A (es) Vacuna de mycoplasma bovis y metodos de uso de la misma.
WO2014018596A3 (en) Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides
AR106800A1 (es) Composiciones que comprenden cepas bacterianas
MX2016014807A (es) Singenes de alfa(1,2)fucosiltransferasa para su utilizacion en la produccion de oligosacaridos fucosilados.
CL2011002852A1 (es) Uso de bacterias del acido lactico probioticas por un tratamiento con calor para la preparacion de composiciones para prevenir o tratar inmunodeficiencias causadas por infecciones bacterianas, virales, fungicas y/o parasitarias.
UA98506C2 (en) Attenuated mycoplasma gallisepticum strains
BR112013000921A2 (pt) tratamento de infecções pulmonares pela administração de tobramicina por aerolização
MX2010008137A (es) Bacterias no patogenas y/o atenuadas capaces de inducir apoptosis en macrofagos, proceso de fabricacion y su usos.
CO6361948A2 (es) Uso de antigeno de mycoplasma bovis
EP4241851A3 (en) Immunogenic compositions
EP2538970A4 (en) TREATMENT OR PREVENTION OF INFECTION
NZ589981A (en) Cattle vaccines comprising a disrupted M. bovis bacterium
CL2017001818A1 (es) Bacteria de ácido láctico y su uso para el tratamiento de mastitis
MX2022003871A (es) Composiciones inmunogénicas.
UA113399C2 (xx) Штам непатогенної грамнегативної бактерії та його застосування в дерматології
WO2014167582A3 (en) Vaccine composition for prophylaxis in ruminants
MX2019006086A (es) Uso de una composicion bacteriana para tratar infecciones en las patas de ungulados.
MX368601B (es) Composicion inmunogenica contra la aeromonas hydrophila.
IL299751A (en) Preparations and methods for disinfection, treatment and prevention of bacterial infections
SG178936A1 (en) Compositions and methods for treating bacterial infections using ceftaroline
MX337145B (es) Composiciones farmaceuticas.
BR112015011944A8 (pt) linhagem bacteriana atenuada estável, seus usos e método para sua geração, composição de vacina
BR112017015585A2 (pt) cepa de bacillus, cultura biologicamente pura, e, composição
MY176015A (en) Immunogenic composition against aeromonas hydrophila

Legal Events

Date Code Title Description
FG Grant or registration